Beijing Huajin Pharmaceutical

Beijing Huajin Pharmaceutical is a Chinese pharmaceutical enterprise focused on the development, production, and sale of chemical medicines and Traditional Chinese Medicine (TCM) preparations. The company maintains a diverse product portfolio that addresses therapeutic areas such as cardiovascular health, respiratory ailments, and digestive disorders. Notable products include Nifedipine sustained-release tablets for hypertension and Compound Danshen tablets for heart health. Beijing Huajin operates GMP-certified manufacturing lines in Beijing and has historically been listed on the National Equities Exchange and Quotations (NEEQ) in China. The firm emphasizes the modernization of traditional formulas alongside the production of high-quality generic chemical drugs. Its distribution network covers various provinces across China, serving both hospital and retail pharmacy channels.